Startseite» Prevention and reduction of scarring in the skin by TGFbeta3: from laboratory discovery to clinical pharmaceutical
Prevention and reduction of scarring in the skin by TGFbeta3: from laboratory discovery to clinical pharmaceutical
Wound Healing and Technology International Symposium. Professor Mark WJ Ferguson “Prevention and reduction of scarring in the skin by TGFbeta3: from laboratory discovery to clinical pharmaceutical”